Presenting
MaxCyte
MaxCyte is a leader in cell transfection, bringing to market its patented flow electroporation technology. MaxCyte is focused in applying its significant capabilities in the discovery, development, and manufacturing of virtually all classes of innovative therapeutics targeting a broad range of chronic and acute diseases. MaxCytes customers and partners utilize its technologies in the development and commercialization of cell-based therapies in regenerative medicine and active cell immunotherapies and in the discovery and development of protein drugs, monoclonal antibodies, vaccines, and small molecule drugs.
Pensana Rare Earths Plc
With Presidential approval and backing from the Angolan Sovereign Wealth Fund, recently LSE listed Pensana Rare Earths Plc is bringing online the first major rare earths in over a decade to help meet the rapidly growing demand for magnet metals critical for electric vehicles and offshore wind turbines.
Quadrise Fuels International
is engaged in the manufacturing and marketing of emulsion fuel for use in power generation, industrial and marine diesel engines and steam generation applications.
ReNeuron Group
ReNeuron Group (RENE) is a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
